drug
as of 2026-07-01rTMS
at a glance
Synthesized from structured facts only — each point cited above.
Mechanism & identity
Modality
DEVICE
Indications
Investigational (via trials)
SchizophreniaSchizo Affective DisorderCatatoniaRefractory Auditory HallucinationsCatatoniaHealthy ControlsBipolar Affective DisorderSchizophrenia Spectrum and Other Psychotic DisordersCognitive ImpairmentBipolar DisorderSchizophreniform DisorderSchizophreniaPsychosis; Schizophrenia-LikeCognitive DysfunctionHallucinationsPsychotic Disorders
Trials
8
Mechanisms of Response to Therapeutic Intervention in Clinical High Risk (CHR) for Psychosis
NCT06542640—Recruiting
RTMS for Refractory Auditory Hallucinations Based on Personalized Targets Using Magnetoencephalography
NCT06802939—Recruiting
Personalized Prospective Study Evaluation of the Efficacy and Safety of Noninvasive Neuromodulation of TMS in Subjects With Catatonia
NCT06176456—Unknown
Repetitive TMS & Cognitive Training in Adults With Schizophrenia
NCT03741751—Terminated
Repetitive Transcranial Magnetic Stimulation (rTMS) Self-Referential Processing (rTMS-SRP)
NCT04068857—Withdrawn
rTMS Treatment for Positive and Negative Symptoms of Schizophrenia
NCT03413527Phase 2, Phase 3Unknown
rTMS in First Episode Psychosis
NCT02131129—Completed
Repetitive Transcranial Magnetic Stimulation
NCT00169689—Completed
KOLs & investigators
6
Facts & assertions
0 sourced
No assertions recorded for this entity.
relationships
The graph out of here
developer
company
trial
indication
indication
indication
indication
indication
KOL
William R. McFarlane, M.D.
personKOL score 5
Joachim Cordes, MD
personKOL score 4
Gary Chaimowitz, MD, FRCPC
personKOL score —
PD Dr. W Wölwer
personKOL score —